Biggest News Aggregation in the World
📰 00tm News

00tm News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from 00tm. Real-time updates on events, politics, business and more.

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports that U.S. Collaboration Partner Announced Second Favorable Safety Report for ZYESAMI (RLF-100TM/aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Life-Threatening COVID-19

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study Relief Reports that U.S. Collaboration Partner Announced Second Favorable Safety Report for ZYESAMI (RLF-100TM/aviptadil) in NIH
Michael Miller Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research Eqs Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science